Stock Earnings

Question 1

How did LGNZZ's recent EPS compare to expectations?

Accepted Answer

The most recent EPS for Ligand Pharmaceuticals Inc is $3.09, beating expectations of $1.96.

Question 2

How did Ligand Pharmaceuticals Inc LGNZZ's revenue perform in the last quarter?

Accepted Answer

Ligand Pharmaceuticals Inc revenue for the last quarter is $3.09

Question 3

What is the revenue estimate for Ligand Pharmaceuticals Inc?

Accepted Answer

According to 11 of Wall street analyst, the revenue estimate of Ligand Pharmaceuticals Inc range from $67.43M to $47.29M

Question 4

What's the earning quality score for Ligand Pharmaceuticals Inc?

Accepted Answer

Ligand Pharmaceuticals Inc has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.

Question 5

When does Ligand Pharmaceuticals Inc report earnings?

Accepted Answer

Ligand Pharmaceuticals Inc next earnings report is expected in 2026-02-04

Question 6

What are Ligand Pharmaceuticals Inc's expected earnings?

Accepted Answer

Ligand Pharmaceuticals Inc expected earnings is $59.97M, according to wall-street analysts.

Question 7

Did Ligand Pharmaceuticals Inc beat earnings expectations?

Accepted Answer

Ligand Pharmaceuticals Inc recent earnings of $86.89M beat expectations.

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	$1.96	$3.09	+57.65%	BEAT
Q2 '25	$1.44	$1.6	+11.11%	BEAT
Q1 '25	$1.23	$1.33	+8.13%	BEAT
Q4 '24	$1.21	$1.27	+4.95%	BEAT
Q3 '24	$1.37	$1.84	+34.3%	BEAT

Ligand Pharmaceuticals Inc (LGNZZ) Price

LGNZZ Stock Price Chart

Latest Earnings Results: Q3 '25

Historical Earnings

Earnings FAQ